Dr. Barry Dworkin

Alzheimer’s prevention Phase 1 trial will look at safety of nasal vaccine. Much to happen before any conclusions can be drawn from this study. Also, @billcarrolltalk and I also discuss the approval of COVID vaccine for 5-11 year-old children.

Medical Mythbusting Commentary for November 22, 2021

Source:
Nasal vaccine to treat Alzheimer’s disease to be tested in U.S. clinical trial

COVID-19 vaccines for children

Related posts:

  1. National Advisory Committee on Immunization prioritizes four groups to first receive Covid-19 vaccine but does not provide the distribution framework whilst the National Academies of Sciences, Engineering, and Medicine does so with caveats.
  2. With the beginning of COVID-19 vaccination in Canada, some are concerned people will prematurely ease up on public health measures before we achieve herd immunity.
  3. Ontario to expand eligibility of COVID-19 boosters for adults 50 and older finally recognizing that this is a three-dose vaccine. #VaccinesWork
  4. End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.